MyFinsight
Home
Blog
About
Repare Therapeutics Inc. (RPTX)
Repare Therapeutics Inc. (RPTX)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$5,169K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from maturities of mark...
Income taxes
Net loss for the period
Others
Negative Cash Flow Breakdown
Purchase of marketable securitie...
Gain on termination of collabora...
Accounts payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-09-30
2025-06-30
Net loss for the period
3,258
-46,787
Share-based compensation expense
1,409
6,047
Depreciation expense
72
2,222
Non-cash lease expense
299
1,295
Foreign exchange gain
-39
117
Net accretion of marketable securities
480
1,006
Gain on sale of technology and other assets
130
5,666
Gain on termination of collaboration agreement
3,257
-
Impairment loss on rou asset
330
-
Prepaid expenses
1,052
-3,006
Other current receivables
-1,463
-67
Other non-current assets
0
-179
Deferred collaboration cost recovery
-
3,257
Accounts payable
-2,667
382
Accrued expenses and other current liabilities
-2,223
-7,652
Operating lease liability, current portion
-302
-1,223
Income taxes
9,149
609
Operating lease liability, net of current portion
0
-88
Deferred revenue
0
0
Net cash used in operating activities
2,651
-45,475
Proceeds from sale of technology and other assets
0
1,000
Proceeds from maturities of marketable securities
10,150
73,662
Purchase of marketable securities
7,613
46,456
Net cash provided by investing activities
2,537
28,206
Proceeds from exercise of stock options
0
0
Proceeds from issuance of common stock under the 2020 employee share purchase plan
30
79
Net cash provided by financing activities
30
79
Effect of exchange rate fluctuations on cash held
-49
129
Net decrease in cash and cash equivalents
5,169
-17,061
Cash and cash equivalents at beginning of period
84,717
-
Cash and cash equivalents at end of period
72,825
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Income taxes
$9,149K
Proceeds from maturities
of marketable...
$10,150K
Net loss for the
period
$3,258K
Other current
receivables
-$1,463K
Share-based compensation
expense
$1,409K
Impairment loss on rou asset
$330K
Non-cash lease expense
$299K
Depreciation expense
$72K
Foreign exchange gain
-$39K
Proceeds from issuance of
common stock under the...
$30K
Net cash used in
operating activities
$2,651K
Net cash provided by
investing activities
$2,537K
Canceled cashflow
$13,368K
Net cash provided by
financing activities
$30K
Canceled cashflow
$7,613K
Net decrease in cash
and cash...
$5,169K
Canceled cashflow
$49K
Gain on termination
of collaboration...
$3,257K
something is missing
-$3,257K
Accounts payable
-$2,667K
Accrued expenses and
other current...
-$2,223K
Prepaid expenses
$1,052K
Net accretion of
marketable securities
$480K
Operating lease
liability, current portion
-$302K
Gain on sale of
technology and other assets
$130K
Purchase of marketable
securities
$7,613K
Effect of exchange rate
fluctuations on cash held
-$49K
Buy us a coffee